— Know what they know.
Not Investment Advice
Also trades as: SDZ.SW (SIX) · $vol 107M · 0SAN.L (LSE) · $vol 27M

SDZNY OTC

Sandoz Group AG
1W: +6.2% 1M: +14.7% 3M: +20.9% YTD: +36.1% 1Y: +59.1% 3Y: +237.7%
$99.36
-0.32 (-0.32%)
Pre-Market: $99.12 (-0.24, -0.24%)
Weekly Expected Move ±3.5%
$90 $94 $97 $101 $104
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Buy · Power 68 · $42.8B mcap · 416M float · 0.0056% daily turnover · Short 34% of daily vol
Credit Risk of going bust: lower than 76% of companies Debt: 12.7% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $1.15 (down 99%), Sandoz Group AG would be worth roughly what it owes.
Total debt $6.20B against a stock market value of $42.81B.
Distance to default 8.75 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.68B (short-term plus half of long-term), stock volatility 31.3%; Altman Z'' 2.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$22.0B +10.7% ▲
5Y CAGR: +6.8%
Total Liabilities
$12.6B +7.7% ▲
5Y CAGR: +7.0%
Shareholders Equity
$9.4B +15.0% ▲
5Y CAGR: +6.6%
Cash & Investments
$1.7B +46.0% ▲
5Y CAGR: +119.1%
Total Debt
$5.7B +17.1% ▲
5Y CAGR: +3.9%
Net Debt
$3.9B +7.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$36M$74M$1.1B$1.2B$1.7B
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$36M$74M$1.1B$1.2B$1.7B
Net Receivables$3.0B$2.1B$3.0B$3.1B$2.8B
Inventory$1.8B$2.0B$2.7B$2.8B$2.8B
Other Current Assets$220M-$4.3B$596M$443M$507M
Total Current Assets$5.1B$100K$7.6B$7.8B$8.2B
Property, Plant & Equip.$1.8B$1.8B$1.9B$2.0B$2.8B
Goodwill & Intangibles$7.0B$6.9B$9.2B$8.9B$9.9B
Long-Term Investments$21M$20M$23M$22M$32M
Other Non-Current Assets$1.5B$1.4B$118M$198M$250M
Total Non-Current Assets$10.9B$10.7B$11.9B$12.1B$13.9B
Total Assets$16.0B$16.2B$19.4B$19.9B$22.0B
— Liabilities —
Accounts Payable$1.0B$1.1B$1.6B$1.5B$1.9B
Short-Term Debt$4.4B$3.7B$269M$129M$603M
Deferred Revenue$4M$3M$0$0$0
Other Current Liabilities$1.4B-$6.2B$2.9B$3.8B$3.3B
Total Current Liabilities$7.6B$23K$5.7B$6.3B$6.9B
Long-Term Debt$15M$28M$4.0B$4.4B$4.7B
Other Non-Current Liab.$547M$443M$596M$511M$535M
Total Non-Current Liabilities$924M$817M$5.1B$5.4B$5.8B
Total Liabilities$8.5B$23K$10.8B$11.7B$12.6B
— Equity —
Common Stock$0$100K$24M$25M$25M
Retained Earnings$7.5B-$23K$6.8B$0$0
Accumulated OCI-$95M-$159M$474M$0$0
Total Stockholders Equity$7.4B$77K$8.6B$8.2B$9.4B
Total Liabilities & Equity$16.0B$16.2B$19.4B$19.9B$22.0B
— Key Metrics —
Total Debt$4.5B$3.9B$4.6B$4.9B$5.7B
Net Debt$248M$3.8B$3.4B$3.7B$3.9B
Total Investments$21M$20M$23M$22M$32M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms